Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...

“These medicines will give people more treatment options and help them to live well for longer,” says Pharmac’s Director Equity and Engagement, Dr Nicola Ngawati. “We expect about 180 people will ...

Because of this you usually won’t be able to have TAE if you have moderate or severe liver damage (cirrhosis). Contact the hospital if you have an increase in pain and get a temperature when you are ...

Another risk is bleeding caused by the needle going into the liver. This is also rare. Your doctor or nurse monitors you closely during and after treatment. Treatment for neuroendocrine cancer can be ...

Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...

Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...

Sadly the disease will kill 9,558 people every year with just over 70% dying within 12 months of their diagnosis. One in 10 ...

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to fund medicines ...

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac’s decision to fund medicines for a further five health conditions, including ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...